#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroblastoma Vernal keratoconjunctivitis Familial hypertriglyceridaemia Rosai-Dorfman syndrome Breast angiosarcoma Germ cell cancer Cardiac arrest Methylmalonic acidaemia Ewing's sarcoma metastatic Neoplasm malignant Colitis ulcerative Leiomyosarcoma metastatic Anaplastic thyroid cancer Dementia Cardiac amyloidosis More trials…

    Learn about Rare Diseases

    Focal segmental glomerulosclerosis – Life with Disease Glomerulonephritis rapidly progressive – Basic Information Haemolytic uraemic syndrome – Trials in Disease Gaucher’s disease type I – Treatment Osteosarcoma recurrent – Trials in Disease Familial amyotrophic lateral sclerosis – Diagnostics Epidermolysis bullosa – Life with Disease Advanced systemic mastocytosis – Life with Disease Familial haemophagocytic lymphohistiocytosis Osteosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lanifibranor Nofazinlimab Ibuprofen Arginine Ciprofloxacin Oxygen Ph.eur. Pantothenate Sodium Human Plasma Protein Mps-215 Ceftolozane Zopiclone Quercetin Neratinib Anakinra Pseudoephedrine Hydrochloride Immunoglobulin G NALMEFENE HYDROCHLORIDE Juniper Berry Oil Fazirsiran Ramucirumab Tryptophan More therapies…

    Learn about Your Condition

    Migraine B-cell lymphoma Brain injury Thalassaemia Hepatobiliary cancer Paraganglion neoplasm Bone metabolism disorder Epithelioid sarcoma Ocular lymphoma Extra-osseous Ewing's sarcoma Neonatal hyperglycaemia Fragile X syndrome Intestinal ischaemia Bacterial vaginosis Metastatic glioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on the Effectiveness and Safety of Brensocatib for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    2 1
    Investigated Drugs:
    • BRENSOCATIB
    Bulgaria France Germany Greece The Netherlands Poland +1

  • Study on the Effectiveness of LY4100511 for Adults with Moderate-to-Severe Plaque Psoriasis

    Not recruiting

    2 1
    Investigated Drugs:
    • Ly4100511
    Czechia Germany Hungary Poland

  • Study on the Effectiveness of IC0624 for Patients with Mild to Moderate Hidradenitis Suppurativa

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • SODIUM BITUMINOSULFONATE DRY SUBSTANCE
    Germany

  • Study on the Safety of INF904 for Patients with Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    • Hidradenitis
    Investigated Drugs:
    • INF904
    Bulgaria Germany Greece Poland

  • Study on the Effects of Deucravacitinib for Patients with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Deucravacitinib
    Germany

  • Study on Long-Term Safety of Briquilimab for Patients with Chronic Urticaria

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Urticaria chronic
    Investigated Drugs:
    • Briquilimab
    Germany
Previous Page
1 … 36 37 38 39 40 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!